HLA-A01 Gene in Nasopharyngeal Carcinoma Patients and Controls in Makassar
Keywords:
HLA-A01 Gene, Nasopharingeal Carcinoma, Epstein Barr VirusAbstract
The aim of this study was to determine the presence of HLA- A01 gene in Nasopharyngeal Carcinoma (NPC) patients and control
References
Roezin A., Adham M.. Karsinoma nasofaring. Dalam:Soepardi EA, Iskandar N, Bashiruddin J, Restuti RD, editor. Buku Ajar Ilmu Kesehatan:Telinga Hidung Tenggorok Kepala dan Leher. Edisi ke 6. Jakarta: Balai Penerbit FKUI; 2007. p. 182-7
Yenita, Asri A. Studi Retrospektif Karsinoma Nasofaring di Sumatera Barat: Reevaluasi Subtipe Histopatologi Berdasarkan Klasifikasi WHO [Tesis]. Padang: Bagian Patologi Anatomi FK-UNAND; 2009
Kuhuwael F.G. Aspek klinis karsinoma nasofaring di RSU Dadi dan RS.Wahidin Sudirohusodo tahun 1990-1999. Disampaikan pada Pertemuan Ilmiah Berkala XV. 2001; Fakultas Kedokteran UNHAS, Makassar.
Punagi AQ, Savitri E. Profil Karsinoma Nasofaring di Rumah sakit Pendidikan FK UNHAS Periode Januari 2004
Bastiana, Kuhuwael FG. Perbandingan Kasus Kanker Kepala Leher dalam Dua Dekade di Makassar. Disampaikan pada Konas PERHATI XV; 5-7 Juli 2010; Makassar
Yang XR, Dlehi S, Pfeiffer R. Evaluation Of Risk Factors for Nasopharyngeal Carcinoma In High-Risk Nasopharyngeal Carcinoma Families in Taiwan. Cancer Epidemiology Biomarkers Prevention. 2005; 14(4) :900-5
McDermott AL, Dutt SN, Watkinson JC. The Aetiology of Nasopharyngeal Carcinoma, Otolaryngology. 2001;26:82-92
Hildesheim A, Apple RJ, Chen CJ, Wang SS, Cheng YJ, Klitz W. Association of HLA Class I and II Allels and Extended Haplotypes with Nasopharyngeal Carcinoma in Taiwan. Journal of the National Cancer Institute.2002;94(23):1780
Pathmanathan R, Raab-Traub. Epstein- Barr virus in Nasopharyngeal Carcinoma, 3th ed, Singapore : VFH Chong, SY Tsao, Amour Publishing, 1999:14-21
Dardari R, Khyatti M, Jouhadi H, Benider A, Ettayebi H, Kahlain A. Study of Human Leukocyte Antigen Class I Phenotypes in Moroccan Patients with Nasopharyngeal Carcinoma. Int J Cancer.2001;92 (2):294
Brennan RM, and Burrrow SR. A Mechanism for the HLA-A*01- Associated risk for EBV +Hodgkin lymphoma and Infectious Mononucleosis. bloodjournal. Hematology library.org. 2008;112(6):2589-90
Hafez MM ,el Wehedy GF ,el Kholy NM. The value of HLA phenotypes in the prognosis of Hodgkin,s lymphoma. Int J Cancer.1985;36:19-22
Falk J, Osoba D. HLA antigen and survival in Hodgkin
Niens M, Jarret RF, Hepkema B, Nolte IM, Diepstra A, Platteel M, et al. HLA-A*02 is Associated with reduced risk and HLA-A01* with increase risk of developing EBV+ Hodgkin lymphoma, bloodjournal. Hematologylibrary.org. 2007; 110(9):3310-5
Huang X, Hepkema B, Nolte I, Kushekhar K, Jongsma T, Veenstra R, et al. HLA-A * 02:07 Is Protection for EBV negative alleles and allele Susceptibility to EBV Positive Classical Hodgkin Lymphoma in China. Cited in PLoS ONE 2012; 7 (2) e31865. doi: 10.1371/journal
Dujfri NI, Peran Ekspresi HLA-A2, Polimorfisme Gen CYP2E1 dan Nitrosamin terhadap Stadium Karsinoma Nasofaring [Disertasi]. Makassar: Program Pasca Sarjana UNHAS; 2014.
Munir D. Peran HLA pada Karsinoma Nasofaring. Majalah Kedokteran Nusantara. 2006;39(3):1-7
Savitri E., Mubarika S. Profil Viral Load Ebstein-Barr Virus dan Titer Antibodi Ig A (VCA-P18+EBNA-1) pada Karsinoma Nasofaring di Makassar dan Yogyakarta .Majalah Kedokteran Indonesia. 2012;62(5):174-7
Krishna SM, James S, Kattoor J, Balaram P. Serum EBV DNA as a Biomarker in primary Nasopharyngeal Carcinoma of Indian Origin. Jpn J Clin Oncol 2004;34(6):307-11.
Pieter N.A.L. Profil Iga(Vca-P18+Ebna1) Dan Viral Load DNA EBV Sebagai Faktor Resiko Keluarga Penderita Karsinoma Nasofaring Dengan EBV Positif [Disertasi]. Makassar: Program Pasca Sarjana UNHAS; 2013.
Savitri E, Kuhuwael FG, Punagi AQ, Agus IG. HLA-A24 Gen Allele At peripheral Blood Samples And Nasopharyngeal Cytobrush In Nasopharyngeal Carcinoma Patients In Makassar. Int J Biol Med Res. In press 2014
Abbas A K, Lichtman AH . Cellular and Molecular Immunology, 5th ed. Philadelphia: WB Saunders;2000:p.3-189
Downloads
Published
How to Cite
Issue
Section
License
Authors who submit papers with this journal agree to the following terms.
